Stoyanova Lab News
Exciting news: Dr. Manoj Kumar joins Stoyanova lab!
Welcome to the team Manoj!
New review article on prostate cancer therapies published
Stoyanova Lab publishes a review article discussing second-generation anti-androgen therapies for prostate cancer. Congratulations Meghan!
Stoyanova Lab Receives NCI R01 Grant
Stoyanova lab is awarded NIH/NCI R01 funding for the proposal entitled:
“Elucidating the Role of UCHL1 in Aggressive Prostate Cancer”
The goal of the project is to identify new molecular mechanisms underlying the development of highly aggressive neuroendocrine prostate cancer and develop new therapies for the matasatic disease.
Congratulations!
Dr. Tanya Stoyanova Receives NCI R01/R37 MERIT Award
Dr. Stoyanova is awarded the NIH/NCI R01/R37 MERIT Award for her proposal entitled:
“Elucidating the Role of Trop2 in Prostate Cancer”
The goal of the project is to test the role of a cell surface receptor activation in aggressive prostate cancer. The study will define novel mechanisms that contribute to the development of advanced prostate cancer and test new therapies for the advanced disease.
Congratulations Dr. Stoyanova!
Michelle Shen, undergraduate student at Stanford, joins the lab. Welcome Michelle!
Michelle Shen Receives VPUE Stanford Undergraduate Research Major Grant for her project entitled:
“Defining Novel Therapeutics for Advanced Neuroendocrine Prostate Cancer”
The goal if the project is to define new therapies for highly aggressive subtype of prostate cancer.
Congratulations Michelle!
Identification of a new driver and therapeutic target for a highly aggressive subtype of prostate cancer
Exciting new results from our lab identifying a new driver and therapeutic target for highly aggressive metastatic prostate cancer with neuroendocrine features are published in PNAS. Congratulations En-Chi!
Jordan Lee, undergraduate student at Stanford, joins the lab. Welcome Jordan!
Exciting news: Mark Buckup and team awarded DEBUT Honorable Mention by the National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Mark and his team receives Honorable Mention designation at the Design by Biomedical Undergraduate Teams (DEBUT) Competition hosted by the NIBIB and VentureWell. Congratulations!